GUARNERI, VALENTINA
GUARNERI, VALENTINA
Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts)
2021 Dal Maso, A.; Pavan, A.; Ferro, A.; Pretelli, G.; Frega, S.; Menis, J.; Pasello, G.; Guarneri, V.; Conte, P. F.; Bonanno, L.
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI)
2020 Dal Maso, A.; Ferro, A.; Lorenzi, M.; Polo, V.; Scattolin, D.; Del Conte, A.; Scoccia, E.; Frega, S.; Bonanno, L.; Indraccolo, S.; Calabrese, F.; Guarneri, V.; Conte, P. F.; Pasello, G.
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW)
2021 Lorenzi, M.; Dal Maso, A.; Ferro, A.; Polo, V.; Scattolin, D.; Macerelli, M.; Follador, A.; Targato, G.; Indraccolo, S.; Frega, S.; Menis, J.; Bonanno, L.; Guarneri, V.; Conte, P. F.; Pasello, G.
186O Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial
2018 Dieci, MARIA VITTORIA; Conte, Pierfranco; Bisagni, G; A Brandes, A; Frassoldati, A; Cavanna, L; Musolino, A; Giotta, F; Rimanti, A; Garrone, O; Bertone, E; Cagossi, K; Sarti, S; Ferro, A; Omarini, C; Maiorana, A; Orvieto, E; Sanders, M; D'Amico, R; Guarneri, Valentina
18F-Fluoroestradiol Positron Emission Tomography In Breast Cancer Patients: Systematic Review Of The Literature &; Meta-Analysis
2016 Evangelista, Laura; Dieci, MARIA VITTORIA; Guarneri, Valentina; Conte, Pierfranco
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features
2021 Bonanno, L.; Dal Maso, A.; Pavan, A.; Zulato, E.; Esposito, G.; Fassan, M.; Nardo, G.; Pasello, G.; Guarneri, V.; Calabrese, F.; Rea, F.; Indraccolo, S.; Conte, P. F.
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
2018 Conte, P; Frassoldati, A; Bisagni, G; Brandes, A A; Donadio, M; Garrone, O; Piacentini, F; Cavanna, L; Giotta, F; Aieta, M; Gebbia, V; Molino, A; Musolino, A; Ferro, A; Maltoni, R; Danese, S; Zamagni, C; Rimanti, A; Cagossi, K; Russo, A; Pronzato, P; Giovanardi, F; Moretti, G; Lombardo, L; Schirone, A; Beano, A; Amaducci, L; Bajardi, E A; Vicini, R; Balduzzi, S; D'Amico, R; Guarneri, V
9 Weeks vs 1 Year Adjuvant Trastuzumab in Combination with Chemotherapy: Preliminary Cardiac Safety Data of the Phase III Multicentric Italian Study Short-HER.
2010 Guarneri, V; Frassoldati, A; Gebbia, V; Bisagni, G; Cavanna, L; Donadio, M; Lelli, G; Musolino, A; Colucci, G; Banna, Gl; Degli Esposti, R; Ferro, A; Grasso, F; Zamagni, C; Amadori, D; Aieta, M; Molino, A; Garrone, O; Aitini, E; Fornari, G; Cascinu, S; Rossi, G; D'Amico, R; Conte, Pierfranco
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases
2022 Griguolo, Gaia; Tosi, Anna; Dieci, Maria Vittoria; Fineberg, Susan; Rossi, Valentina; Ventura, Annavera; Bottosso, Michele; Bauchet, Luc; Miglietta, Federica; Jacob, Jack; Rigau, Valerie; Fassan, Matteo; Jacot, William; Conte, Pierfranco; Rosato, Antonio; Darlix, Amelie; Guarneri, Valentina
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
2020 Prat, Aleix; Guarneri, Valentina; Paré, Laia; Griguolo, Gaia; Pascual, Tomás; Dieci, Maria V; Chic, Núria; González-Farré, Blanca; Frassoldati, Antonio; Sanfeliu, Esther; Cejalvo, Juan M; Muñoz, Montserrat; Bisagni, Giancarlo; Brasó-Maristany, Fara; Urso, Loredana; Vidal, Maria; Brandes, Alba A; Adamo, Barbara; Musolino, Antonino; Miglietta, Federica; Conte, Benedetta; Oliveira, Mafalda; Saura, Cristina; Pernas, Sònia; Alarcón, Jesús; Llombart-Cussac, Antonio; Cortés, Javier; Manso, Luis; López, Rafael; Ciruelos, Eva; Schettini, Francesco; Villagrasa, Patricia; Carey, Lisa A; Perou, Charles M; Piacentini, Federico; D'Amico, Roberto; Tagliafico, Enrico; Parker, Joel S; Conte, Pierfranco
A prognostic model based on nodal status and Ki 67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy
2009 Guarneri, Valentina; F., Piacentini; A., Frassoldati; G., Ficarra; R., D’Amico; S., Giovannelli; Conte, Pierfranco
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy.
2009 Guarneri, Valentina; Piacentini, F; Ficarra, G; Frassoldati, A; Damico, R; Giovannelli, S; Maiorana, A; Jovic, G; Conte, Pierfranco
Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR1, HER22, node-positive, high-risk, early breast cancer (monarchE)
2020 Johnston, S. R. D.; Harbeck, N.; Hegg, R.; Toi, M.; Martin, M.; Shao, Z. M.; Zhang, Q. Y.; Rodriguez, J. L. M.; Campone, M.; Hamilton, E.; Sohn, J.; Guarneri, V.; Okada, M.; Boyle, F.; Neven, P.; Cortes, J.; Huober, J.; Wardley, A.; Tolaney, S. M.; Cicin, I.; Smith, I. C.; Frenzel, M.; Headley, D.; Wei, R.; Antonio, B. S.; Hulstijn, M.; Cox, J.; O'Shaughnessy, J.; Rastogi, P.
Achievements and unmet needs in the management of advanced ovarian cancer
2010 Guarneri, Valentina; Piacentini, F; Barbieri, E; Conte, Pierfranco
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
2004 A., Gennari; P., Bruzzi; C., Orlandini; B., Salvadori; S., Donati; E., Landucci; Guarneri, Valentina; M., Rondini; S., Ricci; Conte, Pierfranco
Acute and subacute toxicities of medical anticancer treatment. ESMO handbook of cancer diagnosis and treatment evaluation, pag 79-99 . Informa Healthcare USA, 2009, ISBN 978-1-841-84703-0
2009 Guarneri, Valentina; Conte, Pierfranco
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
2021 Harbeck, N.; Rastogi, P.; Martin, M.; Tolaney, S. M.; Shao, Z. M.; Fasching, P. A.; Huang, C. S.; Jaliffe, G. G.; Tryakin, A.; Goetz, M. P.; Rugo, H. S.; Senkus, E.; Testa, L.; Andersson, M.; Tamura, K.; Del Mastro, L.; Steger, G. G.; Kreipe, H.; Hegg, R.; Sohn, J.; Guarneri, V.; Cortes, J.; Hamilton, E.; Andre, V.; Wei, R.; Barriga, S.; Sherwood, S.; Forrester, T.; Munoz, M.; Shahir, A.; San Antonio, B.; Nabinger, S. C.; Toi, M.; Johnston, S. R. D.; O'Shaughnessy, J.; Jimenez, M. M.; Johnston, S.; Boyle, F.; Neven, P.; Jiang, Z.; Campone, M.; Huober, J.; Shimizu, C.; Cicin, I.; Wardley, A.; Abuin, G. G.; Zarba, J.; Lim, E.; Sant, P.; Liao, N.; Christiansen, B.; Eigeliene, N.; Martin-Babau, J.; Ettl, J.; Mavroudis, D.; Chiu, J.; Boer, K.; Nagarkar, R.; Paluch-Shimon, S.; Moscetti, L.; Sagara, Y.; Kim, S. -B.; Maciel, M. M.; Tjan-Heijnen, V.; Broom, R.; Lacko, A.; Schenker, M.; Volkov, N.; Sim Yap, Y.; Coccia-Portugal, M.; Angel Garcia Saenz, J.; Andersson, A.; Chao, T. -Y.; Gokmen, E.; Harputluoglu, H.; Berzoy, O.; Patt, D.; Mcarthur, H.; Chew, H.; Chalasani, P.; Kaufman, P.; Tedesco, K.; Graff, S. L.
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: Individual patient data meta-analysis
2015 Marinovich, Michael L; Macaskill, Petra; Irwig, Les; Sardanelli, Francesco; Mamounas, Eleftherios; von Minckwitz, Gunter; Guarneri, Valentina; Partridge, Savannah C.; Wright, Frances C.; Choi, Jae Hyuck; Bhattacharyya, Madhumita; Martincich, Laura; Yeh, Eren; Londero, Viviana; Houssami, Nehmat
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: The ERA project
2018 Pelizzari, G.; Arpino, G.; Biganzoli, L.; Cinieri, S.; De Laurentiis, M.; Del Mastro, L.; Di Leo, A.; Gori, S.; Guarneri, V.; Marchetti, P.; Puglisi, F.
An overview of immune checkpoint inhibitors in breast cancer
2020 Miglietta, Federica; Cona, Maria Silvia; Dieci, Maria Vittoria; Guarneri, Valentina; La Verde, Nicla